Institutions / DIADEMA PARTNERS LP / Holdings
Back to DIADEMA PARTNERS LP

Diadema Partners LP

All holdings · as of Dec 31, 2025

73 positions

CompanyClassValueShares% of portfolio
Vistagen Therapeutics, Inc.VTGNCommon Stock$66.2K100,0000.0%
Edesa Biotech, Inc.—$76.7K54,0250.0%
Inhibrx Biosciences, Inc.—$102.6K1,2990.1%
PURETECH HEALTH PLC—$123.8K7,4420.1%
TALPHERA, INC.—$156.1K136,9230.1%
Foghorn Therapeutics Inc.—$165.4K30,6300.1%
BeOne Medicines Ltd.ONCADR$172.8K7,5000.1%
PLIANT THERAPEUTICS, INC.PLRXCommon Stock$176.8K144,9140.1%
Neuphoria Therapeutics Inc.NEUPCommon Stock$194.0K50,0000.1%
Aardvark Therapeutics, Inc.AARDCommon Stock$208.5K15,8820.1%
HARMONY BIOSCIENCES HOLDINGS INC—$280.6K7,5000.2%
PROQR THRAPEUTICS N V—$338.4K167,5320.2%
PALISADE BIO, INC.—$390.2K166,0490.2%
Immunome Inc.—$483.3K22,5000.3%
UROGEN PHARMA LTD—$510.8K21,8100.3%
Equillium, Inc.—$538.5K347,3930.3%
Stoke Therapeutics, Inc.—$545.3K17,1810.3%
Upstream Bio, Inc.UPBCommon Stock$556.6K20,5000.3%
LIGAND PHARMACEUTICALS INC—$564.8K2,9870.3%
Vir Biotechnology, Inc.—$603.0K100,0000.4%
INDIVIOR PLC—$621.4K17,3200.4%
Viridian Therapeutics, Inc.—$657.1K21,1140.4%
Edgewise Therapeutics, Inc.—$744.5K30,0000.4%
Liquidia CorpLQDACommon Stock$754.7K21,8810.4%
Pelthos Therapeutics Inc.PTHSCommon Stock$775.0K25,0000.5%
AYTU BIOPHARMA INC—$795.0K305,7880.5%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$907.3K25,0000.5%
Inovio Pharmaceuticals, Inc.—$928.6K533,6820.6%
Design Therapeutics, Inc.DSGNCommon Stock$941.0K100,3200.6%
Monte Rosa Therapeutics, Inc.—$976.6K62,2810.6%
PROTHENA CORP PUBLIC LTD CO—$1.02M106,5390.6%
ENANTA PHARMACEUTICALS INC—$1.03M65,1380.6%
VAXCYTE, INC.—$1.06M22,9720.6%
UNIQURE NV—$1.08M45,0000.6%
MAPLIGHT THERAPEUTICS INCMPLTCommon Stock$1.12M63,7910.7%
Trevi Therapeutics, Inc.—$1.22M97,1840.7%
Pacira BioSciences Inc—$1.24M48,0250.7%
SOLENO THERAPEUTICS, INC.—$1.25M26,8920.7%
RIGEL PHARMACEUTICALS, INC.—$1.28M30,0000.8%
Xeris Biopharma Holdings, Inc.—$1.34M170,5680.8%
ASCENDIS PHARMA A/S—$1.46M6,8400.9%
ARDELYX, INC.—$1.47M252,1980.9%
BIOCRYST PHARMACEUTICALS INC—$1.49M190,9280.9%
INVENTIVA SA—$1.55M334,2510.9%
MANNKIND CORP—$1.71M302,0001.0%
Annexon, Inc.—$1.76M350,0001.0%
Ventyx Biosciences, Inc.—$1.81M200,0001.1%
Relmada Therapeutics, Inc.—$1.88M389,3951.1%
PROTAGONIST THERAPEUTICS INC—$1.98M22,7001.2%
Lipocine Inc.LPCNCommon Stock$2.10M260,9391.2%
← PrevPage 1 of 2Next →